Golf Tournament 2012

Annual Golf Tournament

 

The First Annual Sharon Leigh Cancer Organization Golf Tournament


Sharon with Kelli and Mike from Cedar-Sinai
Was an amazing success!
The fundraising effort was very successful and lots of fun was had by everyone. We can't wait until next year!

June 29, 2012 proved to be an incredibly successful fundraising event considering the fact that the tournament, held at Monarch Dunes, was a first time happening. The tournament, the committee, and sponsors were able to raise over $40,000. The purpose of the tournament is for awareness and research for early detection of Ovarian cancer.

This was our signature fundraiser benefiting Cedars Sinai ovarian research.
(Listen to Sharon discuss the golf tournament on the Dave Congalton Show by clicking here)

 

 

Photos from the golf tournament:

Booklet Cover

Welcome



Preparing

One of the Tables



What a Beautiful Day

Getting Started



Checking it Out

Riding in Style



Closest to the Hole

Having Fun



Great Form

A Few Moments to Chat



The Winners

Our souvenir cups



The Raffle

The Wine



The Drawing


(note: below is our letter about the tournament, if you missed it but would still like to donate to help fund early detection of ovarian cancer click the button to the left, or read below.) 

Dear Friend:
If you thought you could perhaps help some of the 70% of women (wives, sisters, daughters, granddaughters) currently diagnosed with ovarian cancer too late to be saved, would you do it?

Ovarian cancer is the deadliest of the gynecological cancers, causing more deaths in the U.S. each year than all other gynecological cancers combined. The five-year survival rate is over 90% and long-term prognosis is good for those women diagnosed with ovarian cancer in Stage 1.

But only 30% of women diagnosed are still in Stage 1. The Sharon Leigh Cancer Organization, Inc., a nonprofit, was created on the Central California Coast to raise research funds and spread the word about the importance of early detection for ovarian cancers.

Now you can help increase the chances that women will benefit from early detection and that research break-throughs for ovarian cancer will emerge. The Sharon Leigh Cancer Organization is establishing its first outreach effort and fundraiser. An estimated 25,000 Central Coast women will be educated about the benefits of early detection of ovarian cancer through promotion of the event. Net proceeds from the inaugural fundraiser will benefit Cedars-Sinai ovarian research. Cedars-Sinai is a national leader in research supporting early detection of women’s cancers.

The First Annual “Ovarian Cancer Benefit Golf Tournament”, hosted by the Sharon Leigh Cancer Organization, will take place Friday, June 29, 2012, at the Monarch Dunes Golf Course. We ask that you consider helping us increase the number of women diagnosed with ovarian cancer in time for effective treatment. Please consider a donation to the Sharon Leigh Cancer Organization or a sponsorship for the First Annual Ovarian Cancer Benefit Golf Tournament.

Respectfully,
Sharon Rude, President
This email address is being protected from spambots. You need JavaScript enabled to view it.
(805) 473-8980

Tuesday, March 03, 2015
English Facebook Spanish Facebook Group English Facebook Group Twitter Ovarian Cancer Google+

Want to stay informed?

Up-to-date info on Ovarian Cancer

Like our Facebook page. Everyday we post the most recent breakthroughs and human interest stories on Ovarian Cancer.

Latest News

Information about ovarian cancer symptoms and treatments. Explore the latest medical research on ovarian cysts and ovarian cancer including including stages of the disease and new treatment options.
  • A surgical algorithm developed and implemented by ovarian cancer specialists dramatically increases the frequency of complete removal of all visible tumor – a milestone strongly tied to improved survival. The algorithm is a framework for a personalized surgical approach that allows surgeons to be "much smarter about whom we operate on up front, providing a more individualized approach to surgery that's led to better results for our patients," said one clinician.
  • The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a new study. Serous ovarian cancers containing a variety of genetically-different cells were more likely to become resistant to treatment and come back again than cancers made of more similar cells. Women with this type of tumor also died sooner than those with less varied tumors.
  • Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
  • Cancer researchers have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies. The molecule also seems to play a role in a wide range of cancers, they report.
  • Taking hormone replacement therapy (HRT) for menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence.
  • Researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in the spread of ovarian cancer. This has enabled them to identify small molecules that can inhibit adhesion and invasion, hallmarks of metastasis.
  • Only 1.3 percent of cancers diagnosed between 2004 and 2010 were cancers of the ovary, but fewer than half of these women survived for five years or more. Researchers have now studied a combination therapy developed to help women with ovarian cancer.
  • Inserting a specific strain of bacteria into the microenvironment of aggressive ovarian cancer transforms the behavior of tumor cells from suppression to immunostimulation, researchers have found.
  • A new study finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, potentially offering ways to improve therapy.